Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)
Clinical trial NCT01405560 · COMPLETED
Trial details
- NCT number
- NCT01405560
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-02
- Primary completion
- 2013-03-29
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.